apalutamide for high-risk prostate cancer | learn about clinical trials
Published 4 years ago • 7K plays • Length 4:23Download video MP4
Download video MP3
Similar videos
-
4:42
androgen annihilation in high-risk biochemically relapsed prostate cancer | learn clinical trials
-
3:48
olaparib zytiga for metastatic castrate-resistant prostate cancer | learn about clinical trials
-
3:28
apalutamide and the titan clinical trial
-
11:57
#prostatecancer clinical trials: the benefits and risks | #markscholzmd #pcri
-
14:53
finding & choosing clinical trials for #prostatecancer | #markscholzmd #alexscholz #pcri
-
5:32
understanding treatment for high-risk prostate cancer | prostate cancer staging guide
-
2:29
update: fda approves apalutamide (erleada) for metastatic castration-sensitive prostate cancer
-
6:16
all about clinical trials for advanced prostate cancer (royal) | prostate cancer staging guide
-
5:14
olaparib and keytruda for advanced prostate cancer | | learn about clinical trials
-
0:53
“i have prostate cancer—how can adding apalutamide to standard treatment improve my outcomes?”
-
5:50
unorthodox treatments for high-risk prostate cancer | prostate cancer staging guide
-
5:11
hormone therapy for high-risk prostate cancer | prostate cancer staging guide
-
3:43
startar: adt apalutamide rt docetaxel for psa-recurrent prostate cancer following rp
-
5:29
overview of azure (high-risk) prostate cancer | prostate cancer staging guide
-
8:33
titan phase 3 trial with apalutamide in metastatic castration sensitive prostate cancer
-
6:12
apalutamide, adt improve outcomes in high-risk prostate cancer post-surgery
-
28:31
prostate cancer highlights from esmo 2022
-
24:19
demystifying clinical trials in prostate cancer
-
3:21
prostate cancer clinical trial: the innovate trial (nrg-gu008)